Juan Pablo Salvador Vico

Tenured Scientist

IQAC

Department

Surfactants and Nanobiotechnology

Research group

Nanobiotechnology for Diagnosis (Nb4D)

Contact

Email

jpablo.salvador@iqac.csic.es

Phone

934006142

Extension

437892

Profiles

ORCID

0000-0002-3608-0634

Twitter

J.-Pablo Salvador

LinkedIn

J.Pablo Salvador

Juan Pablo Salvador Vico

Tenured Scientist

PhD in Chemistry from the University of Barcelona (2007). After obtaining his doctorate, he was hired as an associate researcher at CIBER-BBN (2007-2024). In 2024, he was appointed as a Tenured Scientist at CSIC. His research focuses on antibody production and the development of new diagnostic tools for monitoring drugs/contaminants in the environment, food safety, and health.

He currently leads research in the production of nanobodies with diagnostic and therapeutic applications. He manages national and European projects. He has supervised four doctoral theses (four ongoing) and co-authored more than 50 publications in international scientific journals. Additionally, he has presented his contributions at over 40 (inter)national conferences, including 2 invited lectures. He is also the inventor of two patents, one of which has been successfully licensed. In the last decade, he has participated in projects for the detection of pathogenic bacteria, producing and characterizing antibodies/nanobodies targeting quorum sensing molecules.

UNLOCKING-QS aims to develop diagnostic and therapeutic strategies for bacterial infectious diseases targeting quorum sensing. These innovative approaches are expected to contribute to curbing antimicrobial resistance and improving patient management for better care.
The "Safe and Sustainable by Design" approach requires monitoring throughout the entire life cycle of chemicals. TOXBOX aims to develop an instrument that provides reliable toxicity data under relevant conditions and enables the development of reliable in silico models.
2G_PROVEIL aims to develop, scale up and commercialise a new generation of PROVEIL masks, based on a virucidal nanofibre technology, reaching the PPF3 level and incorporating a sensor to inform the user about the correct fit.